| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
|
Designated Extension States: |
|
BA ME |
|
Designated Validation States: |
|
MA |
| (30) |
Priority: |
27.05.2014 US 201414228241 28.05.2014 US 201414288713 28.05.2014 US 201414288720 28.05.2014 US 201414288716 13.06.2014 US 201462012112 P 20.06.2014 US 201414310811 21.07.2014 US 201414336642 29.07.2014 US 201414446184 08.08.2014 WO PCT/US2014/050427 12.08.2014 US 201414457659 09.09.2014 US 201414481097 22.09.2014 US 201462053619 P 24.09.2014 US 201414495732 31.10.2014 US 201414530556 07.11.2014 US 201414536526 11.11.2014 US 201414538709 13.11.2014 US 201414540333 23.01.2015 US 201514604524 26.01.2015 US 201514605822 28.01.2015 US 201514607985 28.01.2015 US 201514607947 29.01.2015 US 201514608855 18.02.2015 US 201514625457 02.03.2015 US 201514635857 02.03.2015 US 201562127214 P 04.03.2015 US 201514639013 14.04.2015 US 201514686551
|
| (71) |
Applicant: Antecip Bioventures II LLC |
|
New York, NY 10111 (US) |
|
| (72) |
Inventors: |
|
- TABUTEAU, Herriot
New York, New York 10111 (US)
- DINKLA, Eric K.M.
New York, New York 10111 (US)
- JONES, Graeme
Hobart, TAS 7000 (AU)
|
| (74) |
Representative: Green, Mark Charles |
|
Urquhart-Dykes & Lord LLP
One Euston Square
40 Melton Street London NW1 2FD London NW1 2FD (GB) |
|